AJCP / Meeting AbstrActs (partially). These cells were immunohistochemically negative for PR, DOG1, and P63. Metastasis of breast cancer to gingiva with no facial bone involvement is an unusual presentation. The positivity of breast immunomarkers (including GATA3 and mammaglobin) in considerable numbers of salivary gland tumors, make this distinction even more difficult. A negative immunomarker panel of DOG1 and P63 exclude salivary myoepithelial carcinoma, acinic cell carcinoma, mucoepidermoid carcinomas, and oncocytic carcinoma. However, none of them help to distinct salivary ductal carcinoma and mammary analogue secretory carcinoma from metastatic breast carcinoma. Thus histomorphologic comparison of primary breast carcinoma with the gingival tumor still remains the key factor. There is no specific study of BCA-225 immunomarker on salivary duct carcinoma or mammary analogue secretory carcinoma in the literature. Although BCA-225 is a nonspecific marker for breast carcinoma, it may help to exclude these two types of salivary gland tumor in a patient with history of breast ductal carcinoma. 
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Objectives:
The World Health Organization classifies primary sinonasal adenocarcinomas (SNACs) into salivary and non-salivary types. Non-salivary SNACs are separated into intestinal-type (ITAC) and non-ITAC, with both having low-and high-grade categories. Lowgrade non-ITAC is the most uncommon and hence one of the least-thought-of differential diagnoses. In contrast to ITAC, non-ITAC is a less aggressive adenocarcinoma with better clinical outcome. Therefore, its recognition and reliable separation from benign sinonasal glandular proliferations or more aggressive ITAC and salivary types are very important. Non-ITAC has been reported to share some features with seromucinous hamartomas including S100 expression. We herein report two cases of low-grade non-ITAC with S100 expression. Methods: Two cases of non-ITACs were included in the study. Clinical information, computed tomography (CT) imaging, and pathological results were analyzed. Hematoxylin and eosin (H&E), and S100, CK7, CK20, CDX2, TTF-1, napsin-A, synaptophysin, and chromogranin antibody staining were performed.
Results:
The two tumors occurred in elderly patients. CT scans demonstrated soft tissue masses in their nasal cavities. Histology showed subepithelial cellular neoplastic proliferations of monotonous bland round cells forming tightly packed and anastomosing tubules and trabeculae. Highpower view showed low-grade cytological atypia with minimal pleomorphism and hyperchromasia. Small psammoma bodies were also seen. Both tumors had CK7+/CK20-immunophenotype. TTF-1, napsin-A, synaptophysin, and chromogranin stains were negative. Both tumors showed strong cytoplasmic and nuclear staining for S100.
Conclusion:
The finding of S100 staining in both cases is consistent with previously reported incidence of greater
